Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology

Human Molecular Genetics

Volumn 23, Issue 13, 2014, Pages 3432-3444

  Bowerman, Melissa ^a,b   Michalski, John Paul ^a,c   Beauvais, Ariane ^a   Murray, Lyndsay M ^a   DeRepentigny, Yves ^a   Kothary, Rashmi ^a,c,d  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b Montpellier University Medical Center   (France)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCAGON; GLUCOSE; INSULIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 1; PROTEIN KINASE B; SURVIVAL MOTOR NEURON PROTEIN; UNCLASSIFIED DRUG; SMN1 PROTEIN, MOUSE; SURVIVAL MOTOR NEURON PROTEIN 1;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SIZE; CELLULAR DISTRIBUTION; ENZYME PHOSPHORYLATION; GENOTYPE; GLUCAGON BLOOD LEVEL; GLUCAGON SENSITIVITY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HETEROZYGOTE; HYPERGLYCEMIA; HYPERINSULINEMIA; IMMUNOBLOTTING; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID DIET; MALE; MOTONEURON; MOUSE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; SPINAL CORD VENTRAL HORN; SPINAL MUSCULAR ATROPHY; UPREGULATION; WEIGHT GAIN; WILD TYPE; ANIMAL; GENETICS; METABOLISM; OBESITY; PANCREAS; PATHOLOGY; PHENOTYPE;

ANIMALS; MALE; MICE; MUSCULAR ATROPHY, SPINAL; OBESITY; PANCREAS; PHENOTYPE; SURVIVAL OF MOTOR NEURON 1 PROTEIN;

EID: 84902331914     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu052     Document Type: Article

References (60)

1. Crawford, T.O. and Pardo, C.A. (1996) The neurobiology of childhood spinal muscular atrophy. Neurobiol. Dis., 3, 97-110.
2. Pearn, J. (1978) Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J. Med. Genet., 15, 409-413.
3. Lefebvre, S., Burglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M. et al. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell, 80, 155-165.
4. Schrank, B., Gotz, R., Gunnersen, J.M., Ure, J.M., Toyka, K.V., Smith, A.G. and Sendtner, M. (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl Acad. Sci. USA, 94, 9920-9925.
5. Lorson, C.L., Hahnen, E., Androphy, E.J. and Wirth, B. (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl Acad. Sci. USA, 96, 6307-6311.
6. Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G. and Melki, J. (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet., 16, 265-269.
7. Rossoll, W., Jablonka, S., Andreassi, C., Kroning, A.K., Karle, K., Monani, U.R. and Sendtner, M. (2003) Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J. Cell Biol., 163, 801-812.
8. McWhorter, M.L., Monani, U.R., Burghes, A.H. and Beattie, C.E. (2003) Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol., 162, 919-931.
9. Akten, B., Kye, M.J., Hao le, T., Wertz, M.H., Singh, S., Nie, D., Huang, J., Merianda, T.T., Twiss, J.L., Beattie, C.E. et al. (2011) Interaction of survival of motor neuron (SMN) and HuD proteins withmRNAcpg15 rescues motor neuron axonal deficits. Proc. Natl Acad. Sci. USA, 108, 10337-10342.
10. Peter, C.J., Evans, M., Thayanithy, V., Taniguchi-Ishigaki, N., Bach, I., Kolpak, A., Bassell, G.J., Rossoll, W., Lorson, C.L., Bao, Z.Z. et al. (2011) The COPI vesicle complex binds and moves with survival motor neuron within axons. Hum. Mol. Genet., 20, 1701-1711.
11. Bowerman, M., Shafey, D. and Kothary, R. (2007) Smn depletion alters profilin II expression and leads to upregulation of the RhoA/ROCK pathway and defects in neuronal integrity. J. Mol. Neurosci., 32, 120-131.
12. Bowerman, M., Beauvais, A., Anderson, C.L. and Kothary, R. (2010) Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model. Hum. Mol. Genet., 19, 1468-1478.
13. Nolle, A., Zeug, A., van Bergeijk, J., Tonges, L., Gerhard, R., Brinkmann, H., Al Rayes, S., Hensel, N., Schill, Y., Apkhazava, D. et al. (2011) The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin. Hum. Mol. Genet., 20, 4865-4878.
14. van Bergeijk, J., Rydel-Konecke, K., Grothe, C. and Claus, P. (2007) The spinal muscular atrophy gene product regulates neurite outgrowth:importance of the C terminus. FASEB J., 21, 1492-1502.
15. Liu, Q., Fischer, U., Wang, F. and Dreyfuss, G. (1997) The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell, 90, 1013-1021.
16. Zhang, Z., Lotti, F., Dittmar, K., Younis, I., Wan, L., Kasim, M. and Dreyfuss, G. (2008) SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell, 133, 585-600.
17. Buhler, D., Raker, V., Luhrmann, R. and Fischer, U. (1999) Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy. Hum. Mol. Genet., 8, 2351-2357.
18. Sanchez, G., Dury, A.Y., Murray, L.M., Biondi, O., Tadesse, H., El Fatimy, R., Kothary, R., Charbonnier, F., Khandjian, E.W. and Cote, J. (2013) A novel function for the survival motoneuron protein as a translational regulator. Hum. Mol. Genet., 22, 668-684.
19. Kong, L., Wang, X., Choe, D.W., Polley, M., Burnett, B.G., Bosch-Marce, M., Griffin, J.W., Rich, M.M. and Sumner, C.J. (2009) Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J. Neurosci., 29, 842-851.
20. Kariya, S., Park, G.H., Maeno-Hikichi, Y., Leykekhman, O., Lutz, C., Arkovitz, M.S., Landmesser, L.T. and Monani, U.R. (2008) Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum. Mol. Genet., 17, 2552-2569.
21. Murray, L.M., Comley, L.H., Thomson, D., Parkinson, N., Talbot, K. and Gillingwater, T.H. (2008) Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum. Mol. Genet., 17, 949-962.
22. Walker, M.P., Rajendra, T.K., Saieva, L., Fuentes, J.L., Pellizzoni, L. and Matera, A.G. (2008) SMNcomplex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain. Hum. Mol. Genet., 17, 3399-3410.
23. Mutsaers, C.A., Wishart, T.M., Lamont, D.J., Riessland, M., Schreml, J., Comley, L.H., Murray, L.M., Parson, S.H., Lochmuller, H., Wirth, B. et al. (2011) Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum. Mol. Genet., 20, 4334-4344.
24. Martinez-Hernandez, R., Soler-Botija, C., Also, E., Alias, L., Caselles, L., Gich, I., Bernal, S. and Tizzano, E.F. (2009) The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation. J. Neuropathol. Exp. Neurol., 68, 474-481.
25. Bevan, A.K., Hutchinson, K.R., Foust, K.D., Braun, L., McGovern, V.L., Schmelzer, L., Ward, J.G., Petruska, J.C., Lucchesi, P.A., Burghes, A.H. et al. (2010) Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Hum. Mol. Genet., 19, 3895-3905.
26. Shababi, M., Habibi, J., Yang, H.T., Vale, S.M., Sewell, W.A. and Lorson, C.L. (2010) Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum. Mol. Genet., 19, 4059-4071.
27. Heier, C.R., Satta, R., Lutz, C. and DiDonato, C.J. (2010) Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum. Mol. Genet., 19, 3906-3918.
28. Bowerman, M., Swoboda, K.J., Michalski, J.P., Wang, G.S., Reeks, C., Beauvais, A., Murphy, K., Woulfe, J., Screaton, R.A., Scott, F.W. et al. (2012) Glucose metabolism and pancreatic defects in spinal muscular atrophy. Ann. Neurol., 72, 256-268.
29. Foust, K.D., Wang, X., McGovern, V.L., Braun, L., Bevan, A.K., Haidet, A.M., Le, T.T., Morales, P.R., Rich, M.M., Burghes, A.H. et al. (2010) Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat. Biotechnol., 28, 271-274.
30. Porensky, P.N., Mitrpant, C., McGovern, V.L., Bevan, A.K., Foust, K.D., Kaspar, B.K., Wilton, S.D. and Burghes, A.H. (2012) A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Hum. Mol. Genet., 21, 1625-1638.
31. Jablonka, S., Schrank, B., Kralewski, M., Rossoll, W. and Sendtner, M. (2000) Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III. Hum. Mol. Genet., 9, 341-346.
32. Bowerman, M., Murray, L.M., Beauvais, A., Pinheiro, B. and Kothary, R. (2012) A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology. Neuromuscul. Disord., 22, 263-276.
33. Lee, Y.I., Mikesh, M., Smith, I., Rimer, M. and Thompson, W. (2011) Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons. Dev. Biol., 356, 432-444.
34. Kido, Y., Burks, D.J., Withers, D., Bruning, J.C., Kahn, C.R., White, M.F. and Accili, D. (2000) Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J. Clin. Invest., 105, 199-205.
35. Orci, L. and Unger, R.H. (1975) Functional subdivision of islets of Langerhans and possible role of D cells. Lancet, 2, 1243-1244.
36. Gannon, M., Ray, M.K., Van Zee, K., Rausa, F., Costa, R.H. and Wright, C.V. (2000) Persistent expression of HNF6 in islet endocrine cells causes disrupted islet architecture and loss of beta cell function. Development, 127, 2883-2895.
37. Bosco, D., Orci, L. and Meda, P. (1989) Homologous but not heterologous contact increases the insulin secretion of individual pancreatic B-cells. Exp. Cell Res., 184, 72-80.
38. Samols, E. and Stagner, J.I. (1988) Intra-islet regulation. Am. J. Med., 85, 31-35.
39. Postic, C. and Girard, J. (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest., 118, 829-838.
40. Altarejos, J.Y. and Montminy, M. (2011) CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol., 12, 141-151.
41. Quesada, I., Tuduri, E., Ripoll, C. and Nadal, A. (2008) Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes. J. Endocrinol., 199, 5-19.
42. Monani, U.R., Sendtner, M., Coovert, D.D., Parsons, D.W., Andreassi, C., Le, T.T., Jablonka, S., Schrank, B., Rossoll, W., Prior, T.W. et al. (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(2/2) mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet., 9, 333-339.
43. Hammond, S.M., Gogliotti, R.G., Rao, V., Beauvais, A., Kothary, R. and DiDonato, C.J. (2010) Mouse survival motor neuron alleles that mimic SMN2 splicing and are inducible rescue embryonic lethality early in development but not late. PLoS One, 5, e15887.
44. Oh, K.J., Han, H.S., Kim, M.J. and Koo, S.H. (2013) CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis. BMB Rep., 46, 567-574.
45. Jiang, G. and Zhang, B.B. (2003) Glucagon and regulation of glucose metabolism. Am. J. Physiol. Endocrinol. Metab., 284, E671-E678.
46. Leahy, P., Crawford, D.R., Grossman, G., Gronostajski, R.M. and Hanson, R.W. (1999) CREB binding protein coordinates the function of multiple transcription factors including nuclear factor I to regulate phosphoenolpyruvate carboxykinase (GTP) gene transcription. J. Biol. Chem., 274, 8813-8822.
47. El Ouaamari, A., Kawamori, D., Dirice, E., Liew, C.W., Shadrach, J.L., Hu, J., Katsuta, H., Hollister-Lock, J., Qian, W.J., Wagers, A.J. et al. (2013) Liver-derived systemic factors drive beta cell hyperplasia in insulin-resistant states. Cell Rep., 3, 401-410.
48. Longuet, C., Robledo, A.M., Dean, E.D., Dai, C., Ali, S., McGuinness, I., de Chavez, V., Vuguin, P.M., Charron, M.J., Powers, A.C. et al. (2013) Liver-specific disruption of the murine glucagon receptor produces alpha-cell hyperplasia: evidence for a circulating alpha-cell growth factor. Diabetes, 62, 1196-1205.
49. Krones-Herzig, A., Mesaros, A., Metzger, D., Ziegler, A., Lemke, U., Bruning, J.C. and Herzig, S. (2006) Signal-dependent control of gluconeogenic key enzyme genes through coactivator-associated arginine methyltransferase 1. J. Biol. Chem., 281, 3025-3029.
50. Crawford, T.O., Sladky, J.T., Hurko, O., Besner-Johnston, A. and Kelley, R.I. (1999) Abnormal fatty acid metabolism in childhood spinal muscular atrophy. Ann. Neurol., 45, 337-343.
51. Dahl, D.S. and Peters, H.A. (1975) Lipid disturbances associated with spiral muscular atrophy. Clinical, electromyographic, histochemical, and lipid studies. Arch. Neurol., 32, 195-203.
52. Quarfordt, S.H., DeVivo, D.C., Engel, W.K., Levy, R.I. and Fredrickson, D.S. (1970) Familial adult-onset proximal spinal muscular atrophy. Report of a family with type II hyperlipoproteinemia. Arch. Neurol., 22, 541-549.
53. Tein, I., Sloane, A.E., Donner, E.J., Lehotay, D.C., Millington, D.S. and Kelley, R.I. (1995) Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)? Pediatr. Neurol., 12, 21-30.
54. Lamarca, N.H., Golden, L., John, R.M., Naini, A., De Vivo, D.C. and Sproule, D.M. (2013) Diabetic ketoacidosis in an adult patient with spinal muscular atrophy type ii: further evidence of extraneural pathology due to survival motor neuron 1 mutation? J. Child Neurol., 8, 1517-1520.
55. Meister, G. and Fischer, U. (2002) Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs. EMBO J., 21, 5853-5863.
56. Tsai, W.W., Niessen, S., Goebel, N., Yates, J.R. III, Guccione, E. and Montminy, M. (2013) PRMT5 modulates the metabolic response to fasting signals. Proc. Natl Acad. Sci. USA, 110, 8870-8875.
57. Majumder, S., Varadharaj, S., Ghoshal, K., Monani, U., Burghes, A.H. and Jacob, S.T. (2004) Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene. J. Biol. Chem., 279, 14803-14811.
58. Mincheva, S., Garcera, A., Gou-Fabregas, M., Encinas, M., Dolcet, X. and Soler, R.M. (2011) The canonical nuclear factor-kappaB pathway regulates cell survival in a developmental model of spinal cord motoneurons. J. Neurosci., 31, 6493-6503.
59. Shaywitz, A.J. and Greenberg, M.E. (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem., 68, 821-861.
60. DiDonato, C.J., Lorson, C.L., De Repentigny, Y., Simard, L., Chartrand, C., Androphy, E.J. and Kothary, R. (2001) Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. Hum. Mol. Genet., 10, 2727-2736.